U.S. Food and Drug Administration (OPDP / CBER Advertising and Promotional Labeling Branch) · United States

FDA Draft Guidance - Character-Space-Limited Platforms

On character-limited platforms (paid search, short posts, SMS), a prescription drug benefit claim should be accompanied in the same unit by the established name, the most serious risks and a direct link to complete risk information, or the claim should not be made there.

21 U.S.C. 352(a), (n); 21 CFR 202.1(e); FDA Character Space Draft Guidance (2014)

What is FDA Draft Guidance - Character-Space-Limited Platforms?

On character-limited platforms (paid search, short posts, SMS), a prescription drug benefit claim should be accompanied in the same unit by the established name, the most serious risks and a direct link to complete risk information, or the claim should not be made there. Apply to paid search ads, short social posts, SMS and small digital units that name a

US Federal

Read official source

Last reviewed: 2026-11-05

General information, not legal advice.

Who does this rule apply to?

general_audience, general_adults_18plus, customers, health_professionals, patients · Prescription Drug · pharma

Where does this rule apply?

United States

Which marketing channels are covered?

search, search_ads, social_media, paid_social, sms, display

When does this rule take effect?

2026-10-07

What does this rule require?

On character-limited platforms (paid search, short posts, SMS), a prescription drug benefit claim should be accompanied in the same unit by the established name, the most serious risks and a direct link to complete risk information, or the claim should not be made there.

How can marketing teams comply?

Apply to paid search ads, short social posts, SMS and small digital units that name a prescription drug and its benefit.

Where can I read the official source?

Read official source

Key facts

Regulatory authority
U.S. Food and Drug Administration (OPDP / CBER Advertising and Promotional Labeling Branch)
Jurisdiction
United States
Official citation
21 U.S.C. 352(a), (n); 21 CFR 202.1(e); FDA Character Space Draft Guidance (2014)
Published
2026-11-16
Effective date
2026-10-07
Channel
search, search_ads, social_media, paid_social, sms, display
Products
Prescription Drug
Audiences
general_audience, general_adults_18plus, customers, health_professionals, patients

Frequently asked questions

What is FDA Draft Guidance - Character-Space-Limited Platforms?

On character-limited platforms (paid search, short posts, SMS), a prescription drug benefit claim should be accompanied in the same unit by the established name, the most serious risks and a direct link to complete risk information, or the claim should not be made there.

Who does this rule apply to?

general_audience, general_adults_18plus, customers, health_professionals, patients · Prescription Drug · pharma

Where does this rule apply?

United States

Which marketing channels are covered?

search, search_ads, social_media, paid_social, sms, display

When does this rule take effect?

2026-10-07

Request a free compliance scan of your homepage and book a time with Warrant.

Get a free homepage compliance scan